4//SEC Filing
VALEANT PHARMACEUTICALS INTERNATIONAL 4
Accession 0001418812-15-000036
CIK 0000930184operating
Filed
May 26, 8:00 PM ET
Accepted
May 27, 7:03 PM ET
Size
24.6 KB
Accession
0001418812-15-000036
Insider Transaction Report
Form 4
ValueAct Capital Management, LLC
10% Owner
Transactions
- Tax Payment
Common Stock, no par value
2015-05-26$224.63/sh−124$27,854→ 3,117 total - Award
Common Stock, no par value
2015-05-22+1,607→ 3,241 total
Holdings
- 1,352,941(indirect: See footnotes)
Common Stock, no par value
- 18,030,936(indirect: See footnotes)
Common Stock, no par value
UBBEN JEFFREY W
DirectorOther
Transactions
- Tax Payment
Common Stock, no par value
2015-05-26$224.63/sh−124$27,854→ 3,117 total - Award
Common Stock, no par value
2015-05-22+1,607→ 3,241 total
Holdings
- 18,030,936(indirect: See footnotes)
Common Stock, no par value
- 1,352,941(indirect: See footnotes)
Common Stock, no par value
VA Partners I, LLC
10% Owner
Transactions
- Tax Payment
Common Stock, no par value
2015-05-26$224.63/sh−124$27,854→ 3,117 total - Award
Common Stock, no par value
2015-05-22+1,607→ 3,241 total
Holdings
- 18,030,936(indirect: See footnotes)
Common Stock, no par value
- 1,352,941(indirect: See footnotes)
Common Stock, no par value
ValueAct Holdings, L.P.
10% Owner
Transactions
- Award
Common Stock, no par value
2015-05-22+1,607→ 3,241 total - Tax Payment
Common Stock, no par value
2015-05-26$224.63/sh−124$27,854→ 3,117 total
Holdings
- 18,030,936(indirect: See footnotes)
Common Stock, no par value
- 1,352,941(indirect: See footnotes)
Common Stock, no par value
ValueAct Co-Invest Master Fund, L.P.
DirectorOther
Transactions
- Tax Payment
Common Stock, no par value
2015-05-26$224.63/sh−124$27,854→ 3,117 total - Award
Common Stock, no par value
2015-05-22+1,607→ 3,241 total
Holdings
- 1,352,941(indirect: See footnotes)
Common Stock, no par value
- 18,030,936(indirect: See footnotes)
Common Stock, no par value
ValueAct Capital Management, L.P.
10% Owner
Transactions
- Award
Common Stock, no par value
2015-05-22+1,607→ 3,241 total - Tax Payment
Common Stock, no par value
2015-05-26$224.63/sh−124$27,854→ 3,117 total
Holdings
- 18,030,936(indirect: See footnotes)
Common Stock, no par value
- 1,352,941(indirect: See footnotes)
Common Stock, no par value
ValueAct Capital Master Fund, L.P.
10% OwnerOther
Transactions
- Award
Common Stock, no par value
2015-05-22+1,607→ 3,241 total - Tax Payment
Common Stock, no par value
2015-05-26$224.63/sh−124$27,854→ 3,117 total
Holdings
- 18,030,936(indirect: See footnotes)
Common Stock, no par value
- 1,352,941(indirect: See footnotes)
Common Stock, no par value
ValueAct Holdings GP, LLC
10% Owner
Transactions
- Award
Common Stock, no par value
2015-05-22+1,607→ 3,241 total - Tax Payment
Common Stock, no par value
2015-05-26$224.63/sh−124$27,854→ 3,117 total
Holdings
- 18,030,936(indirect: See footnotes)
Common Stock, no par value
- 1,352,941(indirect: See footnotes)
Common Stock, no par value
Footnotes (6)
- [F1]Regular annual grant of restricted stock units equal to $375,000 divided by the closing price of registrant common stock on the date prior to grant, which is the third trading day following the annual meeting.
- [F2]Under an agreement with ValueAct Capital, Jeffrey W. Ubben is deemed to hold the restricted share units for the benefit of ValueAct Capital Master Fund, L.P. and indirectly for (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P.
- [F3]Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F4]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
- [F5]The securities reported herein are directly beneficially owned by ValueAct Capital Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P. , (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P. , (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. Jeffrey W. Ubben is a member of the management board of ValueAct Holdings GP, LLC.
- [F6]The securities reported herein are directly beneficially owned by ValueAct Co-Invest Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Co-Invest Master Fund, L.P. , (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Co-Invest Master Fund, L.P. , (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P. Jeffrey W. Ubben is a member of the management board of ValueAct Holdings GP, LLC.
Documents
Issuer
VALEANT PHARMACEUTICALS INTERNATIONAL
CIK 0000930184
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000930184
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 7:03 PM ET
- Size
- 24.6 KB